Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters
Open Access
- 20 April 2017
- journal article
- research article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 15 (1) , 1-5
Abstract
Hodgkin lymphoma is one of the most prevalent lymphoproliferative disorders in Pakistan; however, no risk factors for this disease have yet to be established in our population. Epstein–Barr virus (EBV) is a well-known risk factor for Hodgkin lymphoma in endemic regions of the world; however, frequency of its association in our population has not been widely studied. Latent membrane protein 1 (LMP1) expression by immunohistochemistry (IHC) is a surrogate marker of EBV in Hodgkin lymphoma. Therefore, we aimed to evaluate the frequency of expression of LMP1 in cases of Hodgkin lymphoma at our institute and its correlation with other clinical and histologic parameters. The study included 66 cases of Hodgkin lymphoma diagnosed at Liaquat National Hospital over a duration of 2 years from January 2014 to December 2015. The slides and blocks of all cases were retrieved, and representative blocks were selected for LMP1 by IHC. LMP1 expression of >10% of cells was considered as positive expression and correlated with histologic subtypes and clinical parameters like age, gender, and site of involvement. The mean age of patients was 35.11 (+20.22). LMP1 expression was found in 68.1% (45/66) of cases of Hodgkin lymphoma. Mean age of the patients with LMP1 expression was 32.04 (+21.02). LMP1 expression was found in 40% cases of lymphocyte-rich, 66.7% of lymphocyte-depleted, 73.9% of mixed cellularity, 66.7% of nodular sclerosis, and 73.7% of classic Hodgkin lymphoma, NOS. No significant correlation of LMP1 expression with any clinical or histological parameter could be established in our studied patient population. A high frequency of expression of LMP1 is seen in cases of Hodgkin lymphoma at our setup comparable to endemic regions of the world; therefore, preventive and treatment protocols should be designed accordingly.Keywords
Funding Information
- Liaquat National Hospital and Medical College (2016)
This publication has 39 references indexed in Scilit:
- Persistence of the Epstein–Barr Virus and the Origins of Associated LymphomasNew England Journal of Medicine, 2004
- Characteristics of Hodgkin's Lymphoma after Infectious MononucleosisNew England Journal of Medicine, 2003
- Hodgkin’s lymphoma: immunohistochemical features and its association with EBV LMP-1. Experience from a South Indian hospitalPathology, 2003
- Epstein–Barr virus (EBV) and Hodgkin's disease in a multi‐ethnic population in MalaysiaHistopathology, 1997
- Epidemiology of EBV and Hodgkin's lymphomaAnnals of Oncology, 1996
- The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas.Archives of Disease in Childhood, 1996
- Analysis of Epstein-Barr virus in hodgkin's disease: Experience of a single university hospital in KoreaJournal of Clinical Laboratory Analysis, 1994
- Epstein-Barr virus latent genes in tumour cells of Hodgkin's diseaseThe Lancet, 1991
- The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replicationCell, 1989
- Detection of Epstein–Barr Viral Genomes in Reed–Sternberg Cells of Hodgkin's DiseaseNew England Journal of Medicine, 1989